BioTras receives patent for spine stimulator: 5 quick facts

BioTras, a Dallas-based biomedical company, received a U.S. patent for its AsTris 1.0 spine stimulator.

Advertisement

Here are five quick facts:

 

1. AsTris 1.0 is a medical training stimulator for interventional pain management.

 

2. The spine stimulator allows providers to analyze needle movement toward the spine.

 

3. Composed of a fusable thermo plastic material, AsTris 1.0 feels like human tissue.

 

4. The company plans to develop future generations of AsTris 1.0 for neurosurgery and orthopedic surgery training.

 

5. Pain management physicians Brandon Knutson, DC, and John East, DO, own BioTras. Dr. East has performed more than 20,000 spinal injections.

 

More articles on devices:
Exectech meets OIG’s 5-year corporate integrity agreement: 5 key notes
Cayenne Medical launches BioWick platform for rotator cuff repair failure: 3 things to know
Senate committee supports expedited medical device approval process: 4 insights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.